Latest News and Updates from Laborie | Laborie

Urology & Urogynecology

Three-Year Data from ROBUST III Confirms Long-Term Durability of Optilume® Drug-Coated Balloon for Recurrent Urethral Strictures

Laborie Medical Technologies Corp. (Laborie), a global leader in diagnostic and therapeutic urology, announced the publication of three-year outcomes from the ROBUST III randomized controlled trial in the Journal of Endourology. The results underscore the long-term durability and safety of the Optilume® Drug-Coated Balloon (DCB) as a minimally invasive treatment for recurrent anterior urethral strictures in men.

Urology & Urogynecology

Optilume Drug-Coated Balloon Shows Long-Term Efficacy for Urethral Strictures: Five-Year Data Published in the Journal of Urology

Urology & Urogynecology

Optilume® BPH Catheter System Issued Category 1 CPT Code by American Medical Association

Obstetrics, Gynecology, & Neonatal

Laborie Medical Technologies to Invest in Medical Technology Start-Up Novocuff

Laborie announced its investment in Novocuff, an early-stage medical technology company headquartered in Mountain View, CA.

Gastroenterology

Laborie Introduces Solar Compact System and Solar Anorectal Manometry Catheter for Enhanced Gastrointestinal Diagnostics

Laborie is proud to introduce the Solar Compact System and Solar Anorectal Manometry Catheter, the first disposable HRAM catheter on the market.

Urology & Urogynecology

Laborie Unveils Positive Study Results for Optilume® BPH Catheter System

Laborie announced positive 2-year and 5-year results from studies for its Optilume® BPH Catheter System.

Urology & Urogynecology

NHS England Reimburses Optilume® Urethral Drug Coated Balloon as Part of the Specialised Services Device Programme

Laborie welcomed the inclusion of Optilume® Urethral Drug-Coated Balloon (DCB) into the National Health Service (NHS) Specialized Services Device Programme (SSDP) as of April 1, 2024.

Urology & Urogynecology

Laborie Medical Technologies Invests in iO Urology and the CarePath Uroflow Device

Laborie Medical Technologies  announced a strategic equity investment in Bright Uro, an early-stage medical technology company headquartered in Irvine, CA.

a laborie device with a hose attached to it

Gastroenterology

Laborie Introduces the Next Generation RenovaRP™Centesis System

Announcing the launch of the RenovaRP™ Centesis System, an innovative fluid drainage device designed to advance patient care and improve efficiency for healthcare professionals.

laborie for dignity for life and brighturo a brighter future

Laborie Medical Technologies Invests in Medical Technology Start-Up Bright Uro

Laborie Medical Technologies  announced a strategic equity investment in Bright Uro, an early-stage medical technology company headquartered in Irvine, CA.

Viewing 10 of 26

Page 1 of 312 3 »